Ameritas Investment Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.6K | Sell |
3,212
-297
| -8% | -$8.19K | ﹤0.01% | 1841 |
|
|
2025
Q1 | $99.5K | Hold |
3,509
| – | – | ﹤0.01% | 1705 |
|
|
2024
Q4 | $146K | Sell |
3,509
-11,567
| -77% | -$481K | ﹤0.01% | 1526 |
|
|
2024
Q3 | $1.01M | Buy |
15,076
+437
| +3% | +$29.2K | 0.03% | 630 |
|
|
2024
Q2 | $1.74M | Sell |
14,639
-121
| -0.8% | -$14.4K | 0.06% | 362 |
|
|
2024
Q1 | $1.57M | Sell |
14,760
-120
| -0.8% | -$12.8K | 0.05% | 442 |
|
|
2023
Q4 | $1.48M | Buy |
14,880
+422
| +3% | +$42K | 0.05% | 444 |
|
|
2023
Q3 | $1.49M | Buy |
14,458
+2,095
| +17% | +$216K | 0.06% | 384 |
|
|
2023
Q2 | $1.5M | Hold |
12,363
| – | – | 0.06% | 419 |
|
|
2023
Q1 | $1.9M | Buy |
12,363
+109
| +0.9% | +$16.7K | 0.08% | 298 |
|
|
2022
Q4 | $2.41M | Sell |
12,254
-660
| -5% | -$130K | 0.1% | 220 |
|
|
2022
Q3 | $1.53M | Sell |
12,914
-267
| -2% | -$31.6K | 0.07% | 340 |
|
|
2022
Q2 | $1.88M | Sell |
13,181
-277
| -2% | -$39.6K | 0.08% | 266 |
|
|
2022
Q1 | $2.32M | Sell |
13,458
-124
| -0.9% | -$21.4K | 0.08% | 266 |
|
|
2021
Q4 | $3.45M | Buy |
13,582
+189
| +1% | +$48K | 0.12% | 167 |
|
|
2021
Q3 | $5.15M | Buy |
13,393
+4,729
| +55% | +$1.82M | 0.19% | 78 |
|
|
2021
Q2 | $2.04M | Buy |
8,664
+187
| +2% | +$43.9K | 0.07% | 310 |
|
|
2021
Q1 | $1.11M | Buy |
8,477
+157
| +2% | +$20.6K | 0.04% | 558 |
|
|
2020
Q4 | $869K | Buy |
8,320
+649
| +8% | +$67.8K | 0.04% | 604 |
|
|
2020
Q3 | $543K | Buy |
+7,671
| New | +$543K | 0.02% | 699 |
|